Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ – Get Free Report) passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $2.40 and traded as low as $2.18. Creative Medical Technology shares last traded at $2.27, with a volume of 8,355 shares.
Creative Medical Technology Price Performance
The business’s fifty day simple moving average is $2.40 and its 200 day simple moving average is $3.12. The firm has a market capitalization of $3.97 million, a price-to-earnings ratio of -0.60 and a beta of 1.78.
Creative Medical Technology Company Profile
Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.
Featured Articles
- Five stocks we like better than Creative Medical Technology
- Find and Profitably Trade Stocks at 52-Week Lows
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- P/E Ratio Calculation: How to Assess Stocks
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Comparing and Trading High PE Ratio Stocks
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Creative Medical Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creative Medical Technology and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20221114203151&h=45&w=95&zc=2){kind=logo}
